The Cannabis Boomer Podcast discusses the growing popularity of cannabis edibles with Teresa Hansen, Director of Edibles at Copperstate Farms. Hansen, a nutritionist and culinary arts graduate, explains the science behind edibles, their delayed onset, and prolonged effects. She also highlights the variety of edible products available, including gummies, beverages, and baked goods, and discusses the importance of proper dosing.

Teresa Hansen, a former research and development chef at Starbucks discusses everything that's new in cannabis edibles and emphasizes the importance of thorough research and development in creating shelf-stable baked goods with consistent cannabis concentrations. She advises new consumers to start with a low dose and gradually increase it to find their ideal experience. Safety is a top priority at Copperstate, with child-resistant packaging and proper labeling being essential to prevent accidental consumption.

The cannabis industry is seeing a growing interest in beverages, with a focus on low-dose options and unique extraction processes like rosin-based gummies and chocolates. These products often incorporate a variety of cannabinoids, such as CBD and CBN, to create different effects and cater to consumer preferences. While terpenes may lose some potency in edibles, the full-spectrum nature of these products can still provide a unique experience.

The Cannabis Boomer Podcast is not just for baby boomers and older adults, but for all adults interested in cannabis and health.

#cannabis #edibles #THC #CBD #CBN #cannabisboomerpodcast #health #wellness

The Cannabis Boomer Podcast is not just for baby boomers and older adults, but also for adults of all ages who are interested in the science of cannabis. Key words for the podcast, in general ,are: baby boomers, cannabis, boomers, marijuana, THC, CBD, health, wellness, science, and aging.

For this particular episode, key words are: cannabis, female orgasm difficulty and disorder, female orgasm, sex, marijuana, THC, CBD, CBN, and women's health.

Dr. Suzanne Mulvehill, a clinical sexologist, discusses the intersection of cannabis and female sexual function, particularly Female Orgasmic Disorder. She highlights the misconceptions surrounding cannabis as a drug rather than a medicine and emphasizes the need for research on its potential benefits for sexual health. Dr. Mulvehill explains how cannabinoids interact with the endocannabinoid system, influencing sexual response, and emphasizes the importance of self-experimentation in finding the right cannabis dosage for individual needs.

Cannabis can help women with orgasm difficulties by quieting cognitive distractions and allowing them to focus on sensations. However, finding the right dosage and method of use is crucial, as too much or too little can inhibit function. Dr. Suzanne Mulvehill and her research partner are developing a training program for doctors and therapists to guide women in using cannabis for sexual issues.

Dr. Suzanne Mulvehill discusses the prevalence of orgasm difficulties in women, highlighting that up to 72% of premenopausal women experience this issue. She explores the potential benefits of cannabis in enhancing sexual experiences, referencing historical rituals and the increasing prevalence of orgasm difficulties in the DSM-5. Dr. Mulvehill emphasizes the need for further research on the effects of cannabis on different types of female orgasms.

Podcast aims to inform cannabis users about cannabis and its effects, emphasizing the information is not medical advice.

The Cannabis Boomer Podcast is not just for baby boomers and older adults, but also for adults of all ages who are interested in the science of cannabis. Key words for the podcast, in general ,are: baby boomers, cannabis, boomers, marijuana, THC, CBD, health, wellness, science, and aging.

For this particular episode, key words are: cannabis, sleep science, marijuana, THC, CBD, CBN, REM. non-REM, and sleep.

Cannabis, particularly THC, alters sleep architecture by increasing non-REM sleep and decreasing REM sleep. While this may be beneficial for conditions like PTSD or insomnia, it could be detrimental for healthy individuals as REM sleep is crucial for learning and memory. The effects of cannabis on sleep diminish over time due to tolerance, and the method of consumption may also impact sleep quality.

Dr. Andrew Kesner discusses his research on cannabis and sleep, particularly focusing on sleep disruption as a withdrawal symptom. He highlights the need for more research on cannabis and sleep, emphasizing the importance of studying sex differences. While acknowledging the potential benefits of cannabis for sleep, he emphasizes the need for further research to understand its effects and potential risks.

The effects of cannabis on sleep are complex and multifaceted, influenced by factors like preexisting pain, anxiety, and age. Animal studies, particularly those using mice, are crucial for understanding the specific brain pathways and mechanisms involved, as they allow for controlled experiments and the use of sophisticated genetic tools. While human studies often rely on self-reported measures, animal research can utilize EEG recordings to provide a more detailed and objective analysis of sleep architecture and quality.

Dr. Isobel Lavender discusses the complexity of studying cannabis and sleep, highlighting the diverse effects of different cannabinoids and the variability in sleep patterns among individuals. She emphasizes the need for consistent research methods and doses to better understand the impact of cannabis on sleep, particularly in relation to sleep disorders like insomnia. Lavender also explores the potential benefits of CBN for reducing sleep onset latency.

The Cannabis Boomer Podcast is not just for baby boomers and older adult, but also for all adults who are interested in the science of cannabis. Key words for the podcast, in general ,are: baby boomers, cannabis, boomers, marijuana, THC, CBD, health, wellness, science, and aging.

For this particular episode, key words are: cannabis, obstructive sleep apnea, marijuana, THC, CBD, and sleep.

A systematic review of the literature on the use of cannabinoids to treat obstructive sleep apnea found only nine unique records, indicating a lack of evidence in this area. While some positive findings were reported, such as improvements in symptoms and a reduction in APNIC episodes, 80% of participants experienced side effects. The hypothesized physiological mechanisms underlying the effects of cannabinoids on obstructive sleep apnea involve endocannabinoids activating CB receptors, potentially improving sleep quality and circadian rhythm.

The review found limited research on the use of cannabinoids for treating obstructive sleep apnea (OSA). While some promising results were observed, the short duration of existing studies (median of three weeks) highlights the need for longer-term randomized controlled trials to better understand the potential benefits and risks of cannabis use for OSA patients. The American Academy of Sleep Medicine currently recommends against using cannabinoids for OSA, but some states, like Minnesota, have included it as a medical indication.

Baby boomers and older adults are increasingly using cannabis, posing a public health risk due to their vulnerability to health issues like cognitive decline and falls. Studies show that older adults, particularly baby boomers, often smoke cannabis, a method associated with higher health risks, and tend to use it in the afternoon and nighttime, increasing the risk of impaired driving. While many claim to use cannabis for medical reasons, it is often used for self-treatment of mental health conditions, rather than approved medical indications.

The relationship between cannabis legalization and opioid use is complex and inconclusive, with mixed results from studies. While some research suggests cannabis may reduce opioid use, others indicate it could increase the risk of substance use disorders. Older adults, particularly those over 65, face unique vulnerabilities related to cannabis use due to biological factors and potential interactions with medications.

Cannabis use among baby boomers and older adults is increasing, often for general wellbeing rather than specific medical conditions. However, the evidence supporting cannabis’s health benefits, particularly for cognitive function, is sparse. To minimize risks, older adults should limit cannabis use, avoid potent products like concentrates, and be mindful of potential impairments, especially when engaging in activities like driving.

The Cannabis Boomer Podcast is for baby boomers and all adults who are interested in the science of cannabis. Key words for the podcast in general are: baby boomers, cannabis, boomers, marijuana, THC, CBD, health, wellness, science, and aging.

For this particular episode, key words are: marijuana rescheduling, marijuana descheduling, cannabis law, and cannabis business law.

Cannabis legal expert Janet Jackim discusses the potential implications of rescheduling cannabis from a Schedule One to a Schedule Three controlled substance. While rescheduling could increase profits for cannabis businesses by allowing tax deductions, it could also lead to increased regulation and restrictions for consumers. The process of rescheduling is complex and involves various governmental agencies, making the future of cannabis legalization uncertain.

Rescheduling cannabis to Schedule Three would require human and animal testing, potentially impacting medical patients and existing state programs. Descheduling would eliminate federal prosecution but likely maintain laws against trafficking and cartel activity. While rescheduling could boost research and industry partnerships, it might also lead to overproduction, price compression, and business closures, favoring consolidation and specialized businesses.

To contact Jane Jackim email her at jjackim@fennemore.com.

The Cannabis Boomer Podcast is for baby boomers and all adults who are interested in the science of cannabis. Key words for the podcast, in general, are: baby boomers, cannabis, boomers, marijuana, THC, CBD, health, wellness, science, and aging.

For this particular, episode key words are: cannabis and marijuana testing, marijuana consumer protections, and cannabis business law.

The cannabis industry faces challenges in consumer protection due to the nature of cannabis as an “experienced good,” where quality can only be determined after consumption. This creates a situation of asymmetric information, where manufacturers know the product quality but consumers do not. Experts highlight issues such as inaccurate labeling, fraudulent testing practices, and the need for improved regulations and consumer protections.

Cannabis testing fraud is a significant issue, with inflated THC percentages and pesticide contamination being common problems. The lack of proper regulations and oversight allows labs to manipulate test results, benefiting cannabis companies at the expense of consumers. To address this, a system like METRC could be used for batch testing at the shelf, eliminating the business relationship between labs and cannabis companies.

There is a lack of sophisticated reviewing of cannabis products, with many reviews being overly positive and lacking professionalism. Concerns are raised about the use of organic pesticides, such as neem oil, which can be harmful when used on cannabis plants. Choosing cannabis products can be challenging, especially for those unfamiliar with the market, and it is important to consider trusted brands and packaging regulations.

Overtaxing the cannabis industry can drive consumers back to the black market, undermining the benefits of legalization. States like Missouri, with lower taxes, demonstrate a thriving market, while high-tax states like those on the West Coast face challenges. The cannabis industry is complex, involving medicine, recreation, and various product categories, making regulation difficult.

Cannabis Boomer podcast aims to educate users about cannabis and its effects, emphasizing the importance of informed consumption.The Cannabis Boomer interviews a diverse panel on consumer protections in the cannabis industry.

 Dr. Ruth Fisher PhD is an economist and cannabis industry expert. She is Co-founder of CannaDynamics. Dr. Fisher is the co-author of The Medical Cannabis Primer: Ushering in the Golden Age of Marijuana.

 Ryan Carlisle is a senior banking consultant to the cannabis industry and one of the first bankers in that industry. Ryan has over 10 years’ of specialty banking experience supporting cannabis businesses. Prior to his banking career, he worked in both medical and adult recreational cannabis businesses.

Trent Hancock is a grower with 30 years of experience and a frequent commenter on consumer fraud in the cannabis industry.Trent is a passionate advocate for cannabis testing reform.

Jeff Rawson, PhD is a Harvard-trained biochemist and founder of the Institute of Cannabis Science. The Institute of Cannabis Science aims to normalize cannabis with labels that accurately report contents.

Chapters in this episode include:

00:00:10 Introduction: Consumer Protection in Cannabis with Four Experts

00:01:27 Dr. Ruth Fisher: Cannabis as an Experience Good & Information Asymmetry

00:03:48 Ryan Carlisle: Banking Perspective on Testing Fraud

00:05:39 Trent Hancock: 30-Year Grower Exposes Testing Manipulation

00:06:57 Dr. Jeff Rawson: From EVALI Victim to Consumer Advocate

00:08:08 Personal Stories: Why These Experts Fight for Cannabis Safety

00:09:38 THC Fraud: Why 30% THC Claims Are Impossible

00:11:42 What Testing Should Look Like: Solutions & Standards

00:13:46 METRC System: How Technology Could Fix Testing

00:16:21 The Coming Litigation Tsunami...

The Cannabis Boomer Podcast is for baby boomers and all adults who are interested in the science of cannabis. Key words for the podcast, in general, are: baby boomers, cannabis, boomers, marijuana, THC, CBD, health, wellness, science, and aging.

For this particular episode, key words are: cannabis, pets, marijuana, THC, CBD, dogs, cats, and verterinary science.

Cannabis, particularly CBD, shows promise in treating certain conditions in pets, such as seizures, pain, and atopic dermatitis. However, research is limited, and THC is generally not recommended due to dogs’ higher sensitivity to its intoxicating effects. If a pet ingests cannabis, it’s crucial to seek veterinary advice, as supportive care may be necessary.

Cannabis can benefit pets similarly to humans, helping with issues like inflammation, osteoarthritis, seizures, anxiety, sleep, and gastrointestinal disorders. While THC can be beneficial, caution is advised due to dogs’ sensitivity to its intoxicating effects. Legal considerations for cannabis use in pets vary by state, and it’s crucial to seek guidance from a veterinarian knowledgeable about cannabis to avoid accidental harm.

Dr. Gary Richter, a veterinarian, discusses the differences between human and veterinary medicine, emphasizing the importance of quality of life in veterinary care. He highlights the potential benefits of cannabis for pets, particularly in managing pain and improving quality of life. Dr. Richter has authored several books on pet health, including “The Ultimate Pet Health Guide,” which dedicates a chapter to cannabis use in pets.